Alain Herrera

Alain Herrera is the founder of Onward Therapeutics SA, founded in 2019, serving as Chief Medical Officer & Director.
Current jobs include Chairman & President at EMERCell SAS; Independent Director at Isofol Medical AB since 2024; Non-Executive Director at International Drug Development Institute SA; Director at Gustave Roussy Foundation, PDC Line Pharma SASU, Fondation A.R.CA.D., Gustave Roussy Transfert, and ErVimmune SA since 2021; Managing Director at Alain Oncologie Consulting and Ad Bio Consulting; and Member-Supervisory Board at Nanobiotix SA since 2011.
Former jobs include Chairman-Europe Region at Chiron Therapeutics, Inc.; Managing Director-Oncology Laboratories at Pierre Fabre SA; Independent Director at Isofol Medical AB from 2018 to 2023; VP-Global Oncology Business Strategy & Development at Sanofi from 2007 to 2008; Head-Oncology Platform at Rhône Poulenc Pharma, Inc.; and MD & Head-Corporate Development at Pharmaengine Europe SARL.